ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FRLN Freeline Therapeutics Holdings PLC

6.48
0.00 (0.00%)
May 30 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Freeline Therapeutics Holdings PLC FRLN NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 6.48 19:00:00
Open Price Low Price High Price Close Price Previous Close
6.48 6.48
more quote information »

Recent News

Date Time Source Heading
4/24/202415:00GLOBEFreeline to Present New Data on its Gaucher and Parkinson’s..
2/25/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
2/22/202415:38EDGAR2Form S-8 POS - Securities to be offered to employees in..
2/22/202415:28EDGAR2Form POS AM - Post-Effective amendments for registration..
2/20/202414:22EDGAR2Form SC 13E3/A - Going private transaction by certain..
2/20/202406:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/20/202406:00GLOBEAcquisition of Freeline by Syncona Becomes Effective
2/12/202415:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/12/202411:00GLOBEFreeline Shareholders Approve Acquisition by Syncona
1/18/202415:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/17/202415:17EDGAR2Form SC 13E3/A - Going private transaction by certain..
12/08/202316:21EDGAR2Form SC 13E3 - Going private transaction by certain issuers
12/01/202307:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/22/202308:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/22/202306:30GLOBESyncona to Acquire Freeline Therapeutics
10/25/202305:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/25/202301:01GLOBEFreeline Presents Positive New Data from Phase 1/2 GALILEO-1..
10/18/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/16/202306:00GLOBEFreeline to Present New Clinical Data for FLT201 in Gaucher..
10/06/202315:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/04/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/04/202306:00GLOBEFreeline Reports Positive Initial Clinical Data from First..
8/15/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/15/202306:00GLOBEFreeline Reports Second Quarter 2023 Financial Results and..
8/08/202306:30GLOBEFreeline Therapeutics to Host Second Quarter 2023 Financial..
7/31/202306:30GLOBEFreeline to Participate in Upcoming Investor Conferences
7/25/202306:30GLOBEFreeline to Host Virtual KOL Event on its Gene Therapy..
6/26/202306:30GLOBEFreeline Announces First Patient Dosed with Its Novel Gene..
6/02/202307:00GLOBEFreeline to Present at 2023 Jefferies Healthcare Conference

Your Recent History

Delayed Upgrade Clock